1,2-dimethylhydrazine multiple interactions ISO RGD:734463 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RIPK3 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:734463 6480464 Ethinyl Estradiol affects the expression of RIPK3 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of RIPK3 mRNA CTD PMID:17557909 17alpha-ethynylestradiol multiple interactions ISO RGD:734463 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RIPK3 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RIPK3 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RIPK3 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:734463 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RIPK3 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of RIPK3 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of RIPK3 mRNA CTD PMID:22298810 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:734463 6480464 Tetrachlorodibenzodioxin results in increased expression of RIPK3 mRNA CTD PMID:19933214 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of RIPK3 mRNA CTD PMID:21346803 2-acetamidofluorene increases expression ISO RGD:734463 6480464 2-Acetylaminofluorene results in increased expression of RIPK3 mRNA CTD PMID:17317680 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:734463 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of RIPK3 mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine increases expression ISO RGD:734463 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of RIPK3 mRNA CTD PMID:20188158 3-chloropropane-1,2-diol multiple interactions ISO RGD:734463 6480464 RIPK3 protein affects the reaction [alpha-Chlorohydrin analog results in increased expression of CXCL1 mRNA] more ... CTD PMID:29860048 3-chloropropane-1,2-diol increases phosphorylation EXP 6480464 alpha-Chlorohydrin results in increased phosphorylation of RIPK3 protein CTD PMID:33187795 3-chloropropane-1,2-diol multiple interactions EXP 6480464 [glycidol co-treated with alpha-Chlorohydrin] results in increased phosphorylation of RIPK3 protein CTD PMID:33187795 3-chloropropane-1,2-diol increases expression ISO RGD:734463 6480464 alpha-Chlorohydrin analog results in increased expression of RIPK3 mRNA, alpha-Chlorohydrin analog results in increased expression of RIPK3 protein CTD PMID:29860048 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin analog results in increased expression of RIPK3 protein, alpha-Chlorohydrin results in increased expression of RIPK3 protein CTD PMID:29860048 , PMID:34915118 4,4'-sulfonyldiphenol increases expression ISO RGD:734463 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of RIPK3 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol affects methylation ISO RGD:734463 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of RIPK3 gene CTD PMID:31683443 4-hydroxyphenyl retinamide increases expression ISO RGD:734463 6480464 Fenretinide results in increased expression of RIPK3 mRNA CTD PMID:28973697 8-Br-cAMP increases expression ISO RGD:1342902 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RIPK3 mRNA CTD PMID:22079614 acetamide increases expression EXP 6480464 acetamide results in increased expression of RIPK3 mRNA CTD PMID:31881176 acrolein multiple interactions EXP 6480464 [ferric oxide analog co-treated with Acrolein] results in increased expression of RIPK3 protein CTD PMID:24847785 all-trans-retinoic acid increases expression ISO RGD:1342902 6480464 Tretinoin results in increased expression of RIPK3 mRNA CTD PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of RIPK3 mRNA CTD PMID:16483693 amosite asbestos decreases methylation ISO RGD:1342902 6480464 Asbestos, Amosite results in decreased methylation of RIPK3 promoter CTD PMID:29626692 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of RIPK3 mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO RGD:1342902 6480464 Antirheumatic Agents results in decreased expression of RIPK3 mRNA CTD PMID:24449571 arsane increases methylation ISO RGD:1342902 6480464 Arsenic results in increased methylation of RIPK3 gene CTD PMID:24525453 arsane affects methylation ISO RGD:1342902 6480464 Arsenic affects the methylation of RIPK3 gene CTD PMID:25304211 arsenic atom increases methylation ISO RGD:1342902 6480464 Arsenic results in increased methylation of RIPK3 gene CTD PMID:24525453 arsenic atom affects methylation ISO RGD:1342902 6480464 Arsenic affects the methylation of RIPK3 gene CTD PMID:25304211 benzo[a]pyrene increases expression ISO RGD:734463 6480464 Benzo(a)pyrene results in increased expression of RIPK3 mRNA CTD PMID:21569818 , PMID:32417428 benzo[a]pyrene multiple interactions ISO RGD:734463 6480464 Acetylcysteine affects the reaction [Benzo(a)pyrene affects the expression of RIPK3 protein] CTD PMID:35777681 benzo[a]pyrene affects expression ISO RGD:734463 6480464 Benzo(a)pyrene affects the expression of RIPK3 protein CTD PMID:35777681 benzo[a]pyrene affects methylation ISO RGD:1342902 6480464 Benzo(a)pyrene affects the methylation of RIPK3 promoter CTD PMID:27901495 benzo[b]fluoranthene increases expression ISO RGD:734463 6480464 benzo(b)fluoranthene results in increased expression of RIPK3 mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate increases expression ISO RGD:734463 6480464 Diethylhexyl Phthalate results in increased expression of RIPK3 mRNA, Diethylhexyl Phthalate results in increased expression of RIPK3 protein CTD PMID:35659966 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of RIPK3 mRNA CTD PMID:18180321 bisphenol A multiple interactions ISO RGD:734463 6480464 necrostatin-1 inhibits the reaction [bisphenol A results in increased expression of RIPK3 protein] CTD PMID:32144343 bisphenol A multiple interactions ISO RGD:1342902 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of RIPK3 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of RIPK3 mRNA CTD PMID:30816183 bisphenol A increases expression ISO RGD:734463 6480464 bisphenol A results in increased expression of RIPK3 mRNA, bisphenol A results in increased expression of RIPK3 protein CTD PMID:30951980 , PMID:32144343 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of RIPK3 mRNA CTD PMID:25181051 bortezomib increases expression ISO RGD:734463 6480464 Bortezomib results in increased expression of RIPK3 protein CTD PMID:26769846 butanal increases expression ISO RGD:1342902 6480464 butyraldehyde results in increased expression of RIPK3 mRNA CTD PMID:26079696 C.I. Natural Red 20 multiple interactions ISO RGD:734463 6480464 shikonin promotes the reaction [RIPK1 protein binds to RIPK3 protein] CTD PMID:23261677 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of RIPK3 mRNA CTD PMID:25993096 carbon nanotube affects expression ISO RGD:734463 6480464 Nanotubes, Carbon affects the expression of RIPK3 mRNA CTD PMID:23845593 carbon nanotube increases expression ISO RGD:734463 6480464 Nanotubes more ... CTD PMID:25554681 carbonyl sulfide increases expression EXP 6480464 carbonyl sulfide results in increased expression of RIPK3 mRNA CTD PMID:19395590 CGP 52608 multiple interactions ISO RGD:1342902 6480464 CGP 52608 promotes the reaction [RORA protein binds to RIPK3 gene] CTD PMID:28238834 chromium(6+) increases expression EXP 6480464 chromium hexavalent ion results in increased expression of RIPK3 protein CTD PMID:36108929 cisplatin increases expression ISO RGD:734463 6480464 Cisplatin results in increased expression of RIPK3 protein CTD PMID:26546572 cisplatin multiple interactions ISO RGD:734463 6480464 4-methyl-N1-(3-phenylpropyl)benzene-1, 2-diamine inhibits the reaction [Cisplatin results in increased expression of RIPK3 protein] CTD PMID:26546572 crocidolite asbestos decreases methylation ISO RGD:1342902 6480464 Asbestos, Crocidolite results in decreased methylation of RIPK3 promoter CTD PMID:29626692 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of RIPK3 mRNA CTD PMID:27523638 dextran sulfate increases expression ISO RGD:734463 6480464 Dextran Sulfate results in increased expression of RIPK3 protein CTD PMID:29496522 dextran sulfate multiple interactions ISO RGD:734463 6480464 dihydrotanshinone I inhibits the reaction [Dextran Sulfate results in increased expression of RIPK3 protein] CTD PMID:29496522 Dihydrotanshinone I multiple interactions ISO RGD:734463 6480464 dihydrotanshinone I inhibits the reaction [[Lipopolysaccharides co-treated with benzyloxycarbonyl-valyl-alanyl-aspartic acid] results in increased expression of RIPK3 protein modified form], dihydrotanshinone I inhibits the reaction [Dextran Sulfate results in increased expression of RIPK3 protein] CTD PMID:29496522 dimethylarsinic acid multiple interactions ISO RGD:734463 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RIPK3 mRNA CTD PMID:34876320 dioxygen multiple interactions ISO RGD:734463 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RIPK3 mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of RIPK3 protein CTD PMID:29605020 doxorubicin multiple interactions EXP 6480464 7-oxozeanol promotes the reaction [Doxorubicin results in increased expression of RIPK3 protein] more ... CTD PMID:34358621 , PMID:34713381 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of RIPK3 protein CTD PMID:34358621 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of RIPK3 mRNA CTD PMID:29391264 ethanol multiple interactions ISO RGD:734463 6480464 cobaltiprotoporphyrin inhibits the reaction [Ethanol results in increased expression of RIPK3 protein] more ... CTD PMID:24946281 , PMID:26769846 ethanol multiple interactions ISO RGD:1342902 6480464 Ethanol promotes the reaction [RIPK1 protein binds to RIPK3 protein] more ... CTD PMID:30853489 , PMID:34474091 ethanol increases expression ISO RGD:1342902 6480464 Ethanol results in increased expression of RIPK3 mRNA, Ethanol results in increased expression of RIPK3 protein CTD PMID:26769846 more ... ethanol increases expression ISO RGD:734463 6480464 Ethanol results in increased expression of RIPK3 protein CTD PMID:24946281 , PMID:26769846 ferric oxide multiple interactions EXP 6480464 [ferric oxide analog co-treated with Acrolein] results in increased expression of RIPK3 protein CTD PMID:24847785 fingolimod hydrochloride increases expression ISO RGD:1342902 6480464 Fingolimod Hydrochloride results in increased expression of RIPK3 protein CTD PMID:25939952 fingolimod hydrochloride multiple interactions ISO RGD:1342902 6480464 RIPK3 mutant form inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of PARP1 protein], RIPK3 mutant form inhibits the reaction [Fingolimod Hydrochloride results in increased phosphorylation of TP53 protein] CTD PMID:25939952 folic acid multiple interactions EXP 6480464 [Folic Acid co-treated with Genistein] inhibits the reaction [amyloid beta-protein (31-35) results in increased expression of RIPK3 mRNA], Folic Acid inhibits the reaction [amyloid beta-protein (31-35) results in increased expression of RIPK3 mRNA] CTD PMID:21205217 folic acid multiple interactions ISO RGD:734463 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RIPK3 mRNA CTD PMID:22206623 fulvestrant multiple interactions ISO RGD:1342902 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of RIPK3 gene CTD PMID:31601247 gallic acid multiple interactions ISO RGD:1342902 6480464 Gallic Acid inhibits the reaction [Ethanol results in increased expression of RIPK3 mRNA] more ... CTD PMID:30853489 genistein multiple interactions EXP 6480464 [Folic Acid co-treated with Genistein] inhibits the reaction [amyloid beta-protein (31-35) results in increased expression of RIPK3 mRNA], Genistein inhibits the reaction [amyloid beta-protein (31-35) results in increased expression of RIPK3 mRNA] CTD PMID:21205217 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of RIPK3 mRNA CTD PMID:22061828 , PMID:33387578 glycerol multiple interactions EXP 6480464 diacerein inhibits the reaction [Glycerol results in increased expression of RIPK3 protein] CTD PMID:30974099 glycerol increases expression EXP 6480464 Glycerol results in increased expression of RIPK3 mRNA, Glycerol results in increased expression of RIPK3 protein CTD PMID:30974099 glycidol increases phosphorylation EXP 6480464 glycidol results in increased phosphorylation of RIPK3 protein CTD PMID:33187795 glycidol multiple interactions EXP 6480464 [glycidol co-treated with alpha-Chlorohydrin] results in increased phosphorylation of RIPK3 protein CTD PMID:33187795 hydrogen peroxide multiple interactions ISO RGD:1342902 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of RIPK3 protein CTD PMID:18951874 hydrogen peroxide increases expression ISO RGD:734463 6480464 Hydrogen Peroxide results in increased expression of RIPK3 protein CTD PMID:35112789 hydrogen peroxide multiple interactions ISO RGD:734463 6480464 [Hydrogen Peroxide co-treated with N-(oxo-5 more ... CTD PMID:31494107 , PMID:35112789 lipopolysaccharide multiple interactions ISO RGD:734463 6480464 [Lipopolysaccharides co-treated with benzyloxycarbonyl-valyl-alanyl-aspartic acid] results in increased expression of RIPK3 protein modified form, dihydrotanshinone I inhibits the reaction [[Lipopolysaccharides co-treated with benzyloxycarbonyl-valyl-alanyl-aspartic acid] results in increased expression of RIPK3 protein modified form] CTD PMID:29496522 melatonin multiple interactions ISO RGD:734463 6480464 Melatonin inhibits the reaction [sodium arsenite results in increased expression of RIPK3 protein] CTD PMID:29763682 melatonin multiple interactions EXP 6480464 [Melatonin co-treated with Thioacetamide] results in increased expression of RIPK3 protein CTD PMID:31967703 metformin multiple interactions ISO RGD:1342902 6480464 [Simvastatin co-treated with Metformin] promotes the reaction [RIPK3 protein binds to RIPK1 protein] more ... CTD PMID:25412314 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of RIPK3 mRNA CTD PMID:16393664 methoxyacetic acid affects expression EXP 6480464 methoxyacetic acid affects the expression of RIPK3 mRNA CTD PMID:20864626 methylarsonic acid multiple interactions ISO RGD:734463 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RIPK3 mRNA CTD PMID:34876320 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of RIPK3 mRNA CTD PMID:31378766 N-acetyl-L-cysteine multiple interactions ISO RGD:734463 6480464 Acetylcysteine affects the reaction [Benzo(a)pyrene affects the expression of RIPK3 protein] CTD PMID:35777681 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of RIPK3 protein CTD PMID:31022188 N-phosphocreatine multiple interactions EXP 6480464 Phosphocreatine inhibits the reaction [Doxorubicin results in increased expression of RIPK3 protein] CTD PMID:34358621 nickel atom increases expression ISO RGD:1342902 6480464 Nickel results in increased expression of RIPK3 mRNA CTD PMID:25583101 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of RIPK3 mRNA CTD PMID:22546817 p-menthan-3-ol increases expression ISO RGD:1342902 6480464 Menthol results in increased expression of RIPK3 mRNA CTD PMID:26760959 paclitaxel multiple interactions EXP 6480464 necrostatin-1 inhibits the reaction [Paclitaxel results in increased expression of RIPK3 protein] CTD PMID:34056794 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of RIPK3 protein CTD PMID:34056794 paracetamol multiple interactions ISO RGD:734463 6480464 3-(4-hydroxyphenyl)-4 more ... CTD PMID:24440347 , PMID:33370591 paracetamol increases expression ISO RGD:1342902 6480464 Acetaminophen results in increased expression of RIPK3 mRNA CTD PMID:26690555 , PMID:27761495 paracetamol affects expression ISO RGD:734463 6480464 Acetaminophen affects the expression of RIPK3 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:734463 6480464 Acetaminophen results in increased expression of RIPK3 protein CTD PMID:24440347 , PMID:33370591 paraquat increases expression EXP 6480464 Paraquat results in increased expression of RIPK3 mRNA CTD PMID:32680482 phenacetin increases expression EXP 6480464 Phenacetin results in increased expression of RIPK3 mRNA CTD PMID:17082564 phenylephrine increases expression ISO RGD:1342902 6480464 Phenylephrine results in increased expression of RIPK3 protein CTD PMID:31605733 phenylhydrazine increases expression EXP 6480464 phenylhydrazine results in increased expression of RIPK3 mRNA CTD PMID:17082564 phenylpropanolamine increases phosphorylation ISO RGD:1342902 6480464 Phenylpropanolamine results in increased phosphorylation of RIPK3 protein CTD PMID:27756839 pirinixic acid multiple interactions ISO RGD:1342902 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RIPK3 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:734463 6480464 pirinixic acid results in decreased expression of RIPK3 mRNA CTD PMID:17426115 Pranoprofen increases expression ISO RGD:1342902 6480464 pyranoprofen results in increased expression of RIPK3 protein CTD PMID:31765691 pterostilbene multiple interactions ISO RGD:1342902 6480464 NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK3 mRNA]] more ... CTD PMID:34474091 quetiapine fumarate increases expression ISO RGD:734463 6480464 Quetiapine Fumarate results in increased expression of RIPK3 protein CTD PMID:31220554 quetiapine fumarate multiple interactions ISO RGD:734463 6480464 Rimonabant inhibits the reaction [Quetiapine Fumarate results in increased expression of RIPK3 protein] CTD PMID:31220554 resveratrol increases expression ISO RGD:734463 6480464 resveratrol results in increased expression of RIPK3 protein CTD PMID:25505154 rimonabant multiple interactions ISO RGD:734463 6480464 Rimonabant inhibits the reaction [Quetiapine Fumarate results in increased expression of RIPK3 protein] CTD PMID:31220554 rotenone increases expression EXP 6480464 Rotenone results in increased expression of RIPK3 protein CTD PMID:31022188 serpentine asbestos decreases methylation ISO RGD:1342902 6480464 Asbestos, Serpentine results in decreased methylation of RIPK3 promoter CTD PMID:29626692 Shikonin multiple interactions ISO RGD:734463 6480464 shikonin promotes the reaction [RIPK1 protein binds to RIPK3 protein] CTD PMID:23261677 silicon dioxide multiple interactions ISO RGD:734463 6480464 necrostatin-1 inhibits the reaction [Silicon Dioxide results in increased phosphorylation of RIPK3 protein] CTD PMID:34843873 silicon dioxide increases phosphorylation ISO RGD:734463 6480464 Silicon Dioxide results in increased phosphorylation of RIPK3 protein CTD PMID:34843873 simvastatin multiple interactions ISO RGD:1342902 6480464 [Simvastatin co-treated with Metformin] promotes the reaction [RIPK3 protein binds to RIPK1 protein] more ... CTD PMID:25412314 SM-164 multiple interactions ISO RGD:734463 6480464 [benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone co-treated with SM 164 co-treated with TNF protein] results in increased phosphorylation of RIPK3 protein more ... CTD PMID:34942311 SM-164 multiple interactions ISO RGD:1342902 6480464 [TNF protein co-treated with SM 164 co-treated with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone] results in increased expression of RIPK3 protein modified form, [ZFP91 protein co-treated with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone co-treated with SM 164 co-treated with TNF protein] results in increased phosphorylation of RIPK3 protein CTD PMID:34523043 , PMID:34942311 sodium arsenate decreases expression ISO RGD:734463 6480464 sodium arsenate results in decreased expression of RIPK3 mRNA CTD PMID:30953684 sodium arsenate multiple interactions ISO RGD:734463 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RIPK3 mRNA CTD PMID:34876320 sodium arsenite multiple interactions ISO RGD:734463 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RIPK3 mRNA, Melatonin inhibits the reaction [sodium arsenite results in increased expression of RIPK3 protein] CTD PMID:29763682 , PMID:34876320 sodium arsenite increases expression ISO RGD:734463 6480464 sodium arsenite results in increased expression of RIPK3 protein CTD PMID:29763682 sodium dichromate increases expression ISO RGD:734463 6480464 sodium bichromate results in increased expression of RIPK3 mRNA CTD PMID:22561333 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of RIPK3 mRNA CTD PMID:25993096 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of RIPK3 mRNA CTD PMID:22561333 tamoxifen affects expression ISO RGD:734463 6480464 Tamoxifen affects the expression of RIPK3 mRNA CTD PMID:17555576 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RIPK3 mRNA CTD PMID:32741896 tetrachloromethane affects expression ISO RGD:734463 6480464 Carbon Tetrachloride affects the expression of RIPK3 mRNA CTD PMID:17484886 theophylline multiple interactions ISO RGD:1342902 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of RIPK3 protein CTD PMID:18951874 thioacetamide multiple interactions EXP 6480464 [Melatonin co-treated with Thioacetamide] results in increased expression of RIPK3 protein CTD PMID:31967703 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of RIPK3 mRNA, Thioacetamide results in increased expression of RIPK3 protein CTD PMID:31967703 , PMID:34492290 titanium dioxide increases expression ISO RGD:734463 6480464 titanium dioxide results in increased expression of RIPK3 mRNA CTD PMID:23557971 Tributyltin oxide increases expression EXP 6480464 bis(tri-n-butyltin)oxide results in increased expression of RIPK3 mRNA CTD PMID:17553608 Triptolide increases expression ISO RGD:734463 6480464 triptolide results in increased expression of RIPK3 mRNA CTD PMID:32835833 valproic acid increases methylation ISO RGD:1342902 6480464 Valproic Acid results in increased methylation of RIPK3 gene CTD PMID:29154799
